Company Research Report: BioBridge Global

Company Overview

• Name: BioBridge Global (BBG)

• Mission: To save and enhance lives through the healing power of human cells and tissue.

• Founded: The origins of the organization date back to 1974.

• Founders: Members of the Bexar County Medical Society, led by Dr. Robert Gossett.

• Key People:

• Martin J. Landon, Chief Executive Officer

• Adrienne Blevins Mendoza, Senior Vice President and Chief Operating Officer, BBG Advanced Therapies

• Rachel-Louise Beddard, Senior Vice President, Chief Medical Officer

• Headquarters: 6211 IH 10 West, San Antonio, Texas 78201

• Number of Employees: Approximately 700 employees

• Revenue: No information is available

• Known For: BBG is known for its contributions through subsidiaries in blood resource management, cell and tissue therapies, medical testing, and research and development of advanced therapies.

Products and Services

Blood Services

• Products Offered:

• Red Blood Cells, Platelets (Single Donor and Platelet Concentrate), Plasma, Cryoprecipitate

• Pioneered Low-Titer O Whole Blood program for emergencies

• Cold-Stored Platelets with a shelf-life of 14 days

• COVID-19 Convalescent Plasma collection and distribution

• Transfusion services and crossmatching testing

• Key Features:

• Supplies blood components to over 100 hospitals

• Conducts hundreds of mobile blood drives each year

• Provides innovative Low-Titer O Whole Blood program

Testing Services

• QualTex Laboratories:

• Products:

• Donor Screening, Microbiology, Advanced Therapies Testing

• Key Features:

• Screening millions of samples for US and international biotech customers

• State-of-the-art automation with ACCELERATOR® a3600 Laboratory Automation System

Biomanufacturing Services

• BBG Advanced Therapies:

• Products:

• Custom biomanufacturing solutions compliant with FDA, EMA, and PMDA requirements

• Key Features:

• Integrated quality management system ensures adherence to cGMP standards

• Equipped to support commercial readiness of cell and gene therapies

Cord Blood Services

• Services:

• Cord blood unit collection and banking for transplantation and research

• Key Features:

• Onsite AABB-accredited laboratory services

• Mononuclear cell isolation and cryopreservation

Tissue Recovery Services

• Services:

• Tissue recovery for transplantation, research, and education

• Autologous tissue storage, tissue storage, and distribution

• Key Features:

• Certified facilities and protocols ensuring regulatory compliance

• Collaboration with local partners for tissue recovery and donation promotion

Recent Developments

• New Subsidiary:

• Establishment of BBG Advanced Therapies to consolidate cell and gene therapy services.

• Led by Adrienne Blevins Mendoza as Chief Operating Officer.

• Commences operation on January 1, 2025.

• New Laboratory Space:

• Opening of a dedicated R&D Analytical Development Lab for assay development and qualification.

• Partnerships:

• Collaboration with the University of Texas at San Antonio through GenCure for the development of cellular therapy products and services.

• Partnership with Velico Inc. for the installation of the FrontlineODP™ Spray Dried Plasma System.

• Community Initiatives:

• Participation in blood drives and community engagement programs like the "210 Rally Cry" and "Light the Night" to raise awareness in healthcare.

• Innovation and Expansion:

• Expansion of cell therapy testing laboratory and ongoing growth in advanced therapies sector.

This information further emphasizes BioBridge Global's role as a dedicated organization in advancing healthcare infrastructure through innovative solutions and community partnerships.